Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.
Institute of Public Health and Clinical Nutrition, Department of Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Tissue Barriers. 2021 Jul 3;9(3):1879719. doi: 10.1080/21688370.2021.1879719. Epub 2021 Jul 19.
The Gastrointestinal (GI) tract is composed of four main barriers: microbiological, chemical, physical and immunological. These barriers play important roles in maintaining GI tract homeostasis. In the crosstalk between these barriers, microbiota and related metabolites have been shown to influence GI tract barrier integrity, and alterations of the gut microbiome might lead to an increase in intestinal permeability. As a consequence, translocation of bacteria and their products into the circulatory system increases, reaching proximal and distal tissues, such as the liver. One of the most prevalent chronic liver diseases, Nonalcoholic Fatty Liver Disease (NAFLD), has been associated with an altered gut microbiota and barrier integrity. However, the causal link between them has not been fully elucidated yet. In this review, we aim to highlight relevant bacterial taxa and their related metabolites affecting the GI tract barriers in the context of NAFLD, discussing their implications in gut homeostasis and in disease.
胃肠道(GI)由四个主要屏障组成:微生物学、化学、物理和免疫学。这些屏障在维持胃肠道内环境稳定方面发挥着重要作用。在这些屏障的相互作用中,微生物群及其相关代谢物已被证明会影响胃肠道屏障的完整性,而肠道微生物组的改变可能导致肠道通透性增加。因此,细菌及其产物易位到循环系统中增加,到达近端和远端组织,如肝脏。非酒精性脂肪性肝病(NAFLD)是最常见的慢性肝病之一,与肠道微生物组改变和屏障完整性受损有关。然而,它们之间的因果关系尚未完全阐明。在这篇综述中,我们旨在强调影响 NAFLD 情况下胃肠道屏障的相关细菌分类群及其相关代谢物,讨论它们在肠道内环境稳定和疾病中的意义。